Unveiling ACADL: A Breakthrough Biomarker for Mesothelioma Diagnosis in Elderly Americans
Mesothelioma, a rare cancer linked to asbestos, is dangerous for elderly Americans. It’s hard to tell the difference between reactive…
Paradigm Shift in Mesothelioma Treatment: Targeting PD-1 Biomarker for Improved Outcomes
A recent study in mesothelioma patients opens a new chapter in the fight against this challenging disease. It enhances our…
Cracking the Code: SPARC, the New Mesothelioma Diagnostic Marker
Scientists from Japan have found a new mesothelioma marker called SPARC that could help doctors diagnose this rare cancer. This…
Breaking Down the Three Types of Mesothelioma: Insights from Recent Research
Mesothelioma is a rare type of cancer that affects a special lining around our organs called the mesothelium. Mesothelioma most…
New Potential Blood Biomarker for Pleural Mesothelioma
A team of researchers just published a study looking at whether a gene called FGF18 can be used as a…
Revolutionizing Mesothelioma Diagnosis: Breakthrough Blood Test Method
A study conducted by researchers from China is the first to use a new method to analyze blood samples of…
Identifying Mesothelioma: How Extracellular Vesicles Could Be the Key
Scientists believe that particles called extracellular vesicles could be used as biomarkers to identify malignant pleural mesothelioma (MPM). Malignant pleural…
New and More Objective Way to Diagnose Mesothelioma
A study published in Cancers looked at a new way to diagnose malignant pleural mesothelioma (MPM). The usual way to…
New Antibody to Diagnose Mesothelioma
Scientists are trying to find ways to diagnose malignant pleural mesothelioma (MPM) more easily. An antibody called SKM9-2 could be…
Predicting Mesothelioma Treatment Response
Certain types of biomarkers can help doctors predict the best chemotherapy treatment for patients with malignant pleural mesothelioma. Researchers from…